secwatch.observer — SEC 8-K summary
======================================

Issuer:     MUSTANG BIO, INC. (MBIO)
CIK:        0001680048
Form:       8-K
Filed at:   2023-07-11T23:59:59+00:00
Accession:  0001104659-23-079819
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Mustang Bio terminates UCLA license for PSCA CAR T program, ends MB-105 development
--------------------------------------------------------------------------------

- Terminated UCLA License Agreement for PSCA CAR T technology, effective ~Aug 9, 2023.
- No early termination penalties incurred.
- Previously terminated PSCA Technology License with City of Hope on May 17, 2023.
- Licensed technology targeted prostate cancer, pancreatic cancer, and other solid tumors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680048/000110465923079819/0001104659-23-079819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680048/000110465923079819/tm2320991d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-079819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer